Bio-Techne (TECH)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
At a market value of $11.5B, Bio-Techne's free cash flow of $263M (fiscal 2026) would need to grow about 15% a year for the stock to be worth today's price. That is faster than the company has grown its free cash flow over the last 9 years.
Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Bio-Techne's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.
Fundamental grade
Five factors scored 1 to 9 from TECH's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Bio-Techne's 10-K filings. The deep dive has 15+ years, quarters and every line.
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.2B | $1.2B | $1.2B |
| Net income | $272M | $285M | $168M | $73M | $182M |
| Free cash flow | $280M | $216M | $236M | $257M | $263M |
| EPS (diluted) | $1.66 | $1.76 | $1.05 | $0.46 | $1.16 |
| Operating margin | 26.8% | 26.3% | 17.8% | 8.4% | 20.7% |
Where the revenue comes from
Revenue by segments, fiscal 2024.
Superinvestors who own TECH
From each investor's latest 13F filing (what a 13F shows). 10 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Ruane, Cunniff & Goldfarb Ruane, Cunniff & Goldfarb |
Trimmed | $237M | 3.7% | Q2 2026 |
| Andrew Redleaf Whitebox Advisors |
New position | $148M | 4.2% | Q2 2026 |
| Lee Ainslie Maverick Capital |
Trimmed | $108M | 0.96% | Q2 2026 |
| Wallace Weitz Weitz Investment Management |
Trimmed | $38M | 2.7% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | $30M | 0.02% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management |
Added | $5M | 0.01% | Q2 2026 |
| Larry Robbins Glenview Capital Management |
Trimmed | $4M | 0.08% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | $2M | 0.00% | Q2 2026 |
| Mario Gabelli GAMCO Investors |
New position | $441,563 | 0.00% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
Trimmed | $127,170 | 0.0% | Q2 2026 |
Insider buying
Open-market purchases by Bio-Techne's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Mar 30, 2026 | Ro Khanna |
0 | $52.04 | — |
| Mar 30, 2026 | Ro Khanna |
0 | $52.04 | — |
| Jan 29, 2026 | Ro Khanna |
0 | $63.98 | — |
| Jan 29, 2026 | Ro Khanna |
0 | $63.98 | — |
| Dec 5, 2025 | April Mcclain Delaney |
0 | $61.68 | — |
| Dec 5, 2025 | April Mcclain Delaney |
0 | $61.68 | — |
| Dec 2, 2025 | April Mcclain Delaney |
0 | $62.95 | — |
| Dec 2, 2025 | April Mcclain Delaney |
0 | $62.95 | — |
| Oct 22, 2025 | April Mcclain Delaney |
0 | $63.79 | — |
| Oct 22, 2025 | April Mcclain Delaney |
0 | $63.79 | — |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when TECH trades at or below it.
Free accounts get 3 price alerts. No card needed.
In the full deep dive
Questions
What growth does Bio-Techne's stock price imply?
At a market value of $11.5B, Bio-Techne would need its free cash flow to grow about 15% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 8% a year.
Are Bio-Techne insiders buying the stock?
10 open-market insider purchases of TECH in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Bio-Techne?
10 of the superinvestors Investingly tracks hold TECH in their latest 13F, including Ruane, Cunniff & Goldfarb, Andrew Redleaf, Lee Ainslie.
Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.